SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-008752
Filing Date
2018-04-23
Accepted
2018-04-23 16:10:26
Documents
5
Period of Report
2018-04-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20180417.htm 8-K 29643
2 EX-10.1 abio-ex101_7.htm EX-10.1 7983
3 EX-99.1 abio-ex991_6.htm EX-99.1 12089
4 GRAPHIC g2018042312374917620171.jpg GRAPHIC 202155
5 GRAPHIC g2018042312374951817959.jpg GRAPHIC 20861
  Complete submission text file 0001564590-18-008752.txt   358541
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 18769007
SIC: 2835 In Vitro & In Vivo Diagnostic Substances